139 related articles for article (PubMed ID: 27374828)
1. Joint and fascial chronic graft-vs-host disease: correlations with clinical and laboratory parameters.
Vukić T; Robinson Smith S; Ljubas Kelečić D; Desnica L; Prenc E; Pulanić D; Vrhovac R; Nemet D; Pavletic SZ
Croat Med J; 2016 Jun; 57(3):266-75. PubMed ID: 27374828
[TBL] [Abstract][Full Text] [Related]
2. National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis.
Baird K; Steinberg SM; Grkovic L; Pulanic D; Cowen EW; Mitchell SA; Williams KM; Datiles MB; Bishop R; Bassim CW; Mays JW; Edwards D; Cole K; Avila DN; Taylor T; Urban A; Joe GO; Comis LE; Berger A; Stratton P; Zhang D; Shelhamer JH; Gea-Banacloche JC; Sportes C; Fowler DH; Gress RE; Pavletic SZ
Biol Blood Marrow Transplant; 2013 Apr; 19(4):632-9. PubMed ID: 23340040
[TBL] [Abstract][Full Text] [Related]
3. The Association of Performance Status and Disease Severity in Patients With Chronic Graft-vs-Host Disease.
Andrews C; Smith S; Kennel M; Schilling S; Kalpakjian C
Arch Phys Med Rehabil; 2019 Apr; 100(4):606-612. PubMed ID: 30205083
[TBL] [Abstract][Full Text] [Related]
4. B regulatory cells and monocyte subpopulations in patients with chronic graft-vs-host disease.
Babić A; Kurić L; Zelić Kerep A; Desnica L; Lelas A; Milošević M; Serventi-Seiwerth R; Duraković N; Peric Z; Mravak Stipetić M; Bilic E; Čeović R; Barešić M; Vukić T; Ljubas Kelečić D; Mazić S; Bojanić I; Hećimović A; Bilic E; Zadro R; Vrhovac R; Pavletic SZ; Batinić D; Pulanić D
Croat Med J; 2021 Apr; 62(2):154-164. PubMed ID: 33938655
[TBL] [Abstract][Full Text] [Related]
5. Glycoprotein YKL-40: a novel biomarker of chronic graft-vs-host disease activity and severity?
Duraković N; Krečak I; Perić Z; Milošević M; Desnica L; Pulanić D; Pusic I; Kušec V; Vrhovac R; Pavletic SZ; Nemet D
Croat Med J; 2016 Jun; 57(3):239-46. PubMed ID: 27374825
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Morbidity and Mortality in Children with Chronic Graft-versus-Host Disease Classified by National Institutes of Health Consensus Criteria after Allogeneic Hematopoietic Stem Cell Transplantation.
Inagaki J; Moritake H; Nishikawa T; Hyakuna N; Okada M; Suenobu S; Nagai K; Honda Y; Shimomura M; Fukano R; Noguchi M; Kurauchi K; Tanioka S; Okamura J
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1973-80. PubMed ID: 26234723
[TBL] [Abstract][Full Text] [Related]
7. Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.
Moon JH; Sohn SK; Lambie A; Ellis L; Hamad N; Uhm J; Gupta V; Lipton JH; Messner HA; Kuruvilla J; Kim D
Biol Blood Marrow Transplant; 2014 Apr; 20(4):556-63. PubMed ID: 24447907
[TBL] [Abstract][Full Text] [Related]
8. Validation of the National Institutes of Health (NIH) scale for oral chronic graft-versus-host disease (cGVHD).
Elad S; Zeevi I; Or R; Resnick IB; Dray L; Shapira MY
Biol Blood Marrow Transplant; 2010 Jan; 16(1):62-9. PubMed ID: 19733252
[TBL] [Abstract][Full Text] [Related]
9. Which questionnaires should we use to evaluate quality of life in patients with chronic graft-vs-host disease?
Perić Z; Desnica L; Duraković N; Ostojić A; Pulanić D; Serventi-Seiwerth R; Prenc E; Basak G; Vrhovac R; Pavletic SZ; Nemet D
Croat Med J; 2016 Feb; 57(1):6-15. PubMed ID: 26935610
[TBL] [Abstract][Full Text] [Related]
10. High frequency of cutaneous manifestations including vitiligo and alopecia areata in a prospective cohort of patients with chronic graft-vs-host disease.
Čeović R; Desnica L; Pulanić D; Serventi Seiwerth R; Ilić I; Grce M; Mravak Stipetić M; Klepac Pulanić T; Bilić E; Bilić E; Milošević M; Vrhovac R; Nemet D; Pavletic SZ
Croat Med J; 2016 Jun; 57(3):229-38. PubMed ID: 27374824
[TBL] [Abstract][Full Text] [Related]
11. Content Validity of the Lee Chronic Graft-versus-Host Disease Symptom Scale as Assessed by Cognitive Interviews.
Merkel EC; Mitchell SA; Lee SJ
Biol Blood Marrow Transplant; 2016 Apr; 22(4):752-758. PubMed ID: 26751003
[TBL] [Abstract][Full Text] [Related]
12. Significant Associations of IgG Glycan Structures With Chronic Graft-Versus-Host Disease Manifestations: Results of the Cross-Sectional NIH Cohort Study.
Prenc E; Pulanic D; Pucic-Bakovic M; Ugrina I; Desnica L; Milosevic M; Pirsl F; Mitchell S; Rose J; Vrhovac R; Nemet D; Lauc G; Pavletic SZ
Front Immunol; 2021; 12():633214. PubMed ID: 34335560
[TBL] [Abstract][Full Text] [Related]
13. Unique abnormalities of CD4(+) and CD8(+) central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis.
Yamashita K; Horwitz ME; Kwatemaa A; Nomicos E; Castro K; Sokolic R; Foster SF; Garofalo M; Choi U; Ryherd M; Brown MR; Leitman SF; Wayne AS; Fowler DH; Bishop MR; Childs RW; Barrett AJ; Pavletic SZ; Malech HL
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):22-30. PubMed ID: 16399598
[TBL] [Abstract][Full Text] [Related]
14. Evolving concepts in prognostic scoring of chronic GvHD.
Lazaryan A; Arora M
Bone Marrow Transplant; 2017 Oct; 52(10):1361-1366. PubMed ID: 28346419
[TBL] [Abstract][Full Text] [Related]
15. Impact of the 2014 NIH chronic graft-versus-host disease scoring criteria modifications assessed in a large cohort of severely affected patients.
Kerep AZ; Broome J; Pirsl F; Curtis LM; Steinberg SM; Mitchell SA; Cowen EW; Pichard DC; Joe GO; Comis LE; Mays JW; Datiles MB; Stratton P; Zolton J; Berger A; Hendricks J; Kenyon M; Baruffaldi J; Titarenko I; Pulanic D; Baird K; Fowler DH; Gress RE; Pavletic SZ
Bone Marrow Transplant; 2019 Jan; 54(1):76-84. PubMed ID: 30089900
[TBL] [Abstract][Full Text] [Related]
16. National Institutes of Health classification for chronic graft-versus-host disease predicts outcome of allo-hematopoietic stem cell transplant after fludarabine-busulfan-antithymocyte globulin conditioning regimen.
Saillard C; Crocchiolo R; Furst S; El-Cheikh J; Castagna L; Signori A; Oudin C; Faucher C; Lemarie C; Chabannon C; Granata A; Blaise D
Leuk Lymphoma; 2014 May; 55(5):1106-12. PubMed ID: 23822538
[TBL] [Abstract][Full Text] [Related]
17. Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD).
Mitchell SA; Leidy NK; Mooney KH; Dudley WN; Beck SL; LaStayo PC; Cowen EW; Palit P; Comis LE; Krumlauf MC; Avila DN; Atlam N; Fowler DH; Pavletic SZ
Bone Marrow Transplant; 2010 Apr; 45(4):762-9. PubMed ID: 19784078
[TBL] [Abstract][Full Text] [Related]
18. Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation.
Herzberg PY; Heussner P; Mumm FH; Horak M; Hilgendorf I; von Harsdorf S; Hemmati P; Rieger K; Greinix H; Freund M; Lee SJ; Holler E; Wolff D
Biol Blood Marrow Transplant; 2010 Dec; 16(12):1707-17. PubMed ID: 20541028
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study.
Grube M; Holler E; Weber D; Holler B; Herr W; Wolff D
Biol Blood Marrow Transplant; 2016 Oct; 22(10):1781-1791. PubMed ID: 27343720
[TBL] [Abstract][Full Text] [Related]
20. Graft versus host disease-related eosinophilic fasciitis: cohort description and literature review.
Hidalgo Calleja C; Martín Hidalgo D; Román Curto C; Vázquez López L; Pérez López E; Cabrero Calvo M; Martín López AÁ; Caballero Barrigón MD; Lopez-Corral L
Adv Rheumatol; 2022 Aug; 62(1):33. PubMed ID: 35999577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
